Nervive, Inc. Company
Nervive is a stock-based Delaware C-corp that develops a new treatment for brain ischemia. Its primary product, VitalFlow Stimulator, is non-invasive platform technology that treats conditions of brain ischemia such as cerebral artery vasospasm, ischemic stroke, and traumatic brain injury. Founded in 2013, Nervive is headquartered in Akron, Ohio.
Investors Number:
3
Technology:
NeuroTech
Headquarters:
Akron, Ohio, United States
Founded Date:
2013-12-31
Industry:
Health Care, Medical, Wellness
Employee Number:
1-10
Last Funding Type:
Grant
Total Funding:
$3.6M
Estimated Revenue:
Less than $1M